Clinical trials

Study name: Self-sampling for Non-attenders to Cervical Cancer Screening (KOPRETINA)
Study type: Prospective, screening
Population: Recruiting
Trial number: NCT04226313
Status: Recruiting
Study name: Pulmonary Condensate: Non-invasive Evaluation of Pulmonary Involvement in Asthma and Cystic Fibrosis
Study type: Prospective, observational
Population: Cystic fibrosis and Asthma patients
Trial number: NCT04157361
Status: Recruiting
Study name: Biomarkers of Endometrial Receptivity (BIOMER)
Study type: Prospective, interventional
Trial number: NCT04619524
Status: Recruiting
Study name: Phase II Open Labeled Trial of Disulfiram with Copper in Metastatic Breast Cancer
Study type: Phase II open labeled clinical trial
Population: Metastatic breast cancer patients
Protocol number: 2016-1-DSF-MBC
Trial number: 2016-001386-81 (EudraCT), NCT03323346
Status: Recruiting
Study name: Clinical Significance of Detecting CEA and CK20 mRNA-positive Cells in Colorectal Cancer Patients
Study type:
Population: Patients with Colorectal Cancer
Trial number: NCT03337347
Status: Completed
Study name: HPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovaginal Swabs
Study type: Prospective, screening
Trial number: NCT04133610
Status: Completed
Study name: Influence of Opioid Analgesia on Circulating Tumor Cells in Open Colorectal Cancer Surgery (POACC-1)
Study type: Randomized, interventional
Population: Colorectal Cancer patients
Trial number: NCT03700411
Status: Completed
Study name: Influence of Opioid Analgesia on Circulating Tumor Cells in Laparoscopic Colorectal Cancer Surgery
Study type: Randomized, interventional
Population: Colorectal Cancer patients
Trial number: NCT03700541
Status: Completed
Study name: Clinical Efficacy and Safety of a Cosmetic Topical Agent, Fluridil, in Male Androgenic Alopecia
Study type: Phase II clinical trial
Population: Males with androgenic alopecia
Protocol number: FLUR-2000
Status: Terminated
Study name: PROTAXEL PHASE I STUDY. Single - center open study of the toxicity, safety, tolerability and kinetics of individually ascending doses of Protaxel in patients with refractory/recurrent ovarian or prostate cancer.
Study type: Phase I clinical trial
Population: Paclitaxel refractory/recurrent advanced ovarian or prostate cancer patients
Protocol number: PTX-I-01 2001
Status: Terminated